biote (BTMD) Current Deferred Revenue: 2021-2024
Historic Current Deferred Revenue for biote (BTMD) over the last 4 years, with FY2024 value amounting to $3.0 million.
- biote's Current Deferred Revenue rose 813.12% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 813.12%. This contributed to the annual value of $3.0 million for FY2024, which is 136.58% down from last year.
- biote's Current Deferred Revenue amounted to $3.0 million in FY2024, which was down 136.58% from $3.0 million recorded in FY2023.
- In the past 5 years, biote's Current Deferred Revenue registered a high of $3.0 million during FY2023, and its lowest value of $1.7 million during FY2021.
- For the 4-year period, biote's Current Deferred Revenue averaged around $2.4 million, with its median value being $2.5 million (2022).
- Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 5277.35% in 2023, then tumbled by 136.58% in 2024.
- biote's Current Deferred Revenue (Annual) stood at $1.7 million in 2021, then grew by 15.25% to $2.0 million in 2022, then surged by 52.77% to $3.0 million in 2023, then decreased by 1.37% to $3.0 million in 2024.
- Its last three reported values are $3.0 million in FY2024, $3.0 million for FY2023, and $2.0 million during FY2022.